Synthesis of ciprofloxacin-conjugated poly (L-lactic acid) polymer for nanofiber fabrication and antibacterial evaluation

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 1463-1477

  Parwe, Sharad P ^a   Chaudhari, Priti N ^a   Mohite, Kavita K ^a   Selukar, Balaji S ^a   Nande, Smita S ^a   Garnaik, Baijayantimala ^a  

^a NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

Antibacterial activity; Ciprofloxacin conjugated polylactides; CP PLA; Drug release; Electrospinning; MDR; Nonwoven nanofibers; Zinc prolinate

Indexed keywords

7 [4 (2 CHLOROACETYL)PIPERAZIN 1 YL] 1 CYCLOPROPYL 6 FLUORO 1,4 DIHYDRO 4 OXOQUINOLINE 3 CARBOXYLIC ACID; CARBOXYLIC ACID DERIVATIVE; CIPROFLOXACIN; DIPENTAERYTHRITOL; GLYCEROL; LAURYL ALCOHOL; NANOFIBER; PENTAERYTHRITOL; POLYLACTIC ACID; UNCLASSIFIED DRUG; ZINC; ZINC PROLINATE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CATALYST; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ELECTROSPINNING; ESCHERICHIA COLI; GEL PERMEATION CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NANOFABRICATION; NONHUMAN; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; SYNTHESIS;

ANTIBACTERIAL ACTIVITY; CIPROFLOXACIN CONJUGATED POLYLACTIDES; CP-PLA; DRUG RELEASE; ELECTROSPINNING; MDR; NONWOVEN NANOFIBERS; ZINC PROLINATE;

ANTI-BACTERIAL AGENTS; CELL SURVIVAL; CIPROFLOXACIN; LACTIC ACID; NANOCAPSULES; NANOFIBERS; PARTICLE SIZE; POLYMERS; STAPHYLOCOCCUS AUREUS;

EID: 84897102834     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S54971     Document Type: Article

References (40)

1. Jagur-Grodzinski J. Biomedical application of functional polymers. React Funct Polym. 1999;39(2):99-138.
2. Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. Polymeric systems for controlled drug release. Chem. Rev. 1999;99(11): 3186-3198.
3. Merkli A, Tabatabay C, Gurny R, Heller J. Biodegradable polymers for the controlled release of ocular drugs. Prog Poly Sci. 1998;23(3): 563-580.
4. Ueda H, Tabata Y. Polyhydroxyalkanonate derivatives in current clinical applications and trials. Adv Drug Deliv Rev. 2003;55(4):501-518.
5. Albertsson AC, Varma IK. Recent developments in ring opening polymerization of lactones for biomedical applications. Biomacromolecules. 2003;4(6):1466-1486.
6. Storey RF, Sherman JW. Kinetics and mechanism of the stannous octoate-catalyzed bulk polymerization of ε-caprolactone. Macromolecules. 2002;35(5):1504-1512.
7. Okada M. Chemical syntheses of biodegradable polymers. Prog Poly Sci. 2002;27(1):87-133.
8. Kowalski A, Duda A, Penczek S. Mechanism of cyclic ester polymerization initiated with tin(II) octoate. Macromolecules fitted with tin(II) alkoxide species observed directly in MALDI-TOF spectra. Macromolecules. 2000;33(3):689-695.
9. Sobczak M, Kolodziejski W. Polymerization of cyclic esters initiated by carnitine and tin (II) octoate. Molecules. 2009;14(2):621-632.
10. Duda A, Biela T, Kowalski A, Libiszowski J. Amines as (co)initiators of cyclic esters' polymerization. Polimery. 2005;50(7-8):501-508.
11. Cai Q, Zhao Y, Bei J, Xi F, Wang S. Synthesis and properties of star-shaped polylactide attached to poly(amidoamine) dendrimer. Biomacromolecules. 2003;4(3):828-834.
12. Kobayashi S, Uyama H, Kimura S. Enzymatic polymerization. Chem Rev. 2001;101(12):3793-3818.
13. Lee SH, Hyun Kim S, Han YK, Kim YH. Synthesis and degradation of end-group-functionalized polylactide. J Poly Sci Part A. 2001;39(7): 973-985.
14. Williams CK, Breyfogle LE, Choi SK, et al. A highly active zinc catalyst for the controlled polymerization of lactide. J Am Chem Soc. 2003;125(37):11350-11359.
15. Sobczak M. Synthesis and characterization of polyester conjugates of ciprofloxacin. Eur J Med Chem. 2010;45(9):3844-3849.
16. Caço AI, Varanda F, Pratas de Melo MJ, Dias AMA, Dohrn R, Marrucho IM. Solubility of antibiotics in different solvents. Part II. Non-hydrochloride forms of tetracycline and ciprofloxacin. Ind Eng Chem Res. 2008;47(21):8083-8089.
17. Tsou TL, Tang ST, Huang YC, Wu JR, Young JJ, Wang HJ. Poly(2-hydroxyethyl methacrylate) wound dressing containing ciprofloxacin and its drug release studies. J Materials Sci. 2005;16:95-100.
18. Unnithan AR, Barakat NA, Pichiah PB, et al. Wound-dressing materials with antibacterial activity from electrospun polyurethane-dextran nanofiber mats containing ciprofloxacin HCl. Carbohydr Polym. 2012;90(4): 1786-1793.
19. Parshikov IA, Heinze TM, Moody JD, Freeman JP, Williams AJ, Sutherland JB. The fungus Pestalotiopsis guepini as a model for biotransformation of ciprofloxacin and norfloxacin. Appl Microbiol Biotechnol. 2001;56(3-4):474-477.
20. Md-Saleh SR, Chilvers EC, Kerr KG, et al. Synthesis of citrate-ciprofloxacin conjugates. Bioorg Med Chem Lett. 2009;19(5):1496-1498.
21. Parshikov IA, Freeman JP, Lay JO, Beger RD, Williams AJ, Sutherland JB. Microbiological transformation of enrofloxacin by the fungus Mucor ramannianus. Appl Environ Microbiol. 2000;66(6):2664-2667.
22. Sobczak M. Synthesis and characterization of polyester conjugates of ciprofloxacin. Eur J Med Chem. 2010;45(9):3844-3849.
23. National Committee for Clinical Laboratory Standards. Methods for Dilution Antibacterial Susceptibility Tests for Bacteria that Grow Aerobically-Fifth Edition: Approved Standard M7-A5. Wayne PA: NCCLS; 2000.
24. Melo MJP, Varanda FR, Dohrn R, Marrucho IM. Solubility of ciprofloxacin and moxifloxacin in different solvents: the effect of the HCl group. Proceedings of the EMPROMER, 2nd Mercosur Congress on Chemical Engineering and 4th Mercosur Congress on Process Systems Engineering; August 14-18; 2005, Rio de Janeiro, Brazil.
25. Park KE, Lee KY, Lee SJ, Park WH. Surface characteristics of plasma-treated PLGA nanofibers. Macromol Sym. 2007;249-250(1):103-108.
26. Xu CY, Inai R, Kotaki M, Ramakrishna S. Aligned biodegradable nanofibrous structure: a potential scaffold for blood vessel engineering. Biomaterials. 2004;25(5):877-886.
27. Woo GL, Mittelman MW, Santerre JP. Synthesis and characterization of a novel biodegradable antimicrobial polymer. Biomaterials. 2000;21(12):1235-1246.
28. Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997;61(3):377-392.
29. Ashammakhi N, Veiranto M, Suokas E, Tiainen J, Niemelä SM, Törmälä P. Innovation in multifunctional bioabsorbable osteoconductive drug-releasing hard tissue fixation devices. J Mater Sci Mater Med. 2006;17(12):1275-1282.
30. Koort JK, Makinen TJ, Suokas E, et al. Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant. Acta Orthop. 2008;79(2):295-301.
31. Nagy L, Ishii K, Karatas A, et al. Water dissection technique of Toth for opening neurosurgical cleavage planes. Surg Neurol. 2006;65(1):38-41; discussion 41.
32. Martinez B, Lairion F, Pena MB, Di Rocco P, Nacucchio MC. In vitro ciprofloxacin release from poly(lactide-co-glycolide) microspheres. J Microencapsul. 1997;14(2):155-161.
33. Darbre T, Machuqueiro M. Zn-proline catalyzed direct aldol reaction in aqueous media. Chem Commun (Camb). 2003;9:1090-1091.
34. Buschle-Diller G, Cooper J, Xie Z, Wu Y, Waldrup J, Ren X. Release of antibiotics from electrospun bicomponent fibers. Cellulose. 2007;14:553-552.
35. Wachsen O, Reichert KH, Kruger RP, Much H, Schulz G. Thermal decomposition of biodegradable polyesters, 3 Studies on the mechanism of thermal degradation of oligo-L-lactide using SEC, LACCC and MALDI-TOF MS. Polymer Degrad Stabil. 1997;55:225-231.
36. Nielen MWF. MALDI TOF mass spectrometry of synthetic polymers. Mass Spectrometry Rev. 1999;18:309-344.
37. Venugopal RS. Application of polymer nanofibers in biomedicine and biotechnology. Appl Biochem Biotechnol. 2005;125(3):147-157.
38. Shen LL. Quinoline-DNA interaction. In: Hooper DC, Rubinstein E, editors. Quinolone Antimicrobial Agents. 2nd ed. Washington, DC: American Society for Microbiology. 1993;77-95.
39. Hooper DC, Wolfson JS. Mechanisms of quinolone action and bacterial killing. In: DC Hooper, Rubinstein E, editors. Quinolone Antimicrobial Agents. 2nd ed. Washington, DC: American Society for Microbiology. 1993;53-75.
40. Shen LL, Mitscher LA, Sharma PN, et al. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding model. Biochemistry. 1989;28(9):3886-3894.